Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT.

    ... (SAA) and the prognosis is poor. The recovery of host- hematopoiesis , autologous recovery (AR), after allogeneic HSCT is a rare ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. Unraveling the molecular pathophysiology of myelodysplastic syndromes.

    ... define myelodysplastic syndromes (MDS): clonal hematopoiesis , aberrant differentiation, peripheral cytopenias, and risk ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. Therapeutic modalities for patients with lower-risk myelodysplastic syndromes: current options and future directions.

    ... of disease. Current therapies are aimed at promoting hematopoiesis , inhibiting apoptosis , and reducing the risk of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. The search for better prognostic models in myelodysplastic syndromes.

    ... bone marrow disorders characterized by a failure of hematopoiesis and an increased propensity for transformation to acute ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. 5-Azacytidine in myelodysplastic syndromes: a clinical practice guideline.

    ... Myelodysplastic syndrome (MDS) is a clonal disorder of hematopoiesis that results in peripheral blood cytopenias and a marked ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group.

    ... bone marrow disorders characterized by ineffective hematopoiesis , peripheral cytopenias, and a substantial risk of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. An update on the treatment of myelodysplastic syndromes.

    ... affecting about 300,000 people worldwide. Ineffective hematopoiesis and clonal proliferation result in significant cytopenias in ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Epigenetic therapy in myelodysplastic syndromes.

    ... - with ineffective, inadequate, and dysplastic hematopoiesis , and with an increased risk of life-threatening infections, ...

    Research Article last updated 10/11/2011 - 5:58pm.

  9. Decitabine in the treatment of myelodysplastic syndromes.

    ... stem cell disorders characterized by ineffective hematopoiesis , peripheral blood cytopenias and a propensity to transform ...

    Research Article last updated 10/11/2011 - 5:58pm.

  10. Myelodysplastic syndromes.

    ... of stem cell disorders characterized by impaired hematopoiesis resulting in low peripheral blood counts. The majority of ...

    Research Article last updated 10/11/2011 - 5:58pm.